已收盘 05-22 16:00:00 美东时间
+0.030
+0.09%
今日重点评级关注:Canaccord Genuity:维持Sagimet Biosciences"买入"评级,目标价从28美元升至49美元;HC Wainwright & Co.:维持Fate Therapeutics"买入"评级,目标价从5美元升至7美元
05-05 11:40
Barclays analyst Pablo Monsivais maintains Corporacion Inmobiliaria (NYSE:VTMX) with a Overweight and raises the price target from $40 to $41.
05-04 22:39
Corporacion Inmobiliaria (NYSE:VTMX) reported first-quarter financial results o...
04-27 16:03
Vesta Real Estate (NYSE:VTMX) reported quarterly earnings of $0.05 per share which met the analyst consensus estimate. This is a 0 percent decrease over earnings of $0.05 per share from the same period last year. The
04-24 04:04
Companies Reporting Before The Bell • Popular (NASDAQ:BPOP) is estimated to rep...
04-23 19:11
Corporacion Inmobiliaria Vesta shares are trading higher after the company repo...
02-21 02:10
Corporacion Inmobiliaria (NYSE:VTMX) just disclosed its Q4 earnings on Thursday...
02-20 05:04
Companies Reporting Before The Bell • Deere (NYSE:DE) is expected to report qua...
02-19 19:11
Vesta Real Estate (NYSE:VTMX) is gearing up to announce its quarterly earnings ...
02-19 00:02
今日重点评级关注:巴克莱:维持Iovance Biotherapeutics"超配"评级,目标价从9美元升至10美元;摩根大通:上调Recursion Pharmaceuticals评级至"超配",目标价从10美元升至11美元
2025-12-18 10:54